| --- | --- | --- | --- | --- | --- | |-------------------------------------------------|-------|-------|-------|-------|------------| | | | | | | | | | | | | | | | | | | | | | | INVESTOR OVERVIEW Fourth Quarter/Full Year 2021 | | | | | | | March 2022 | | | | | NYSE: FTK | Forward-Looking Statements Certain statements set forth in this presentation constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) re ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-13270 FLOTEK INDUSTRIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0023731 (State of other jurisdiction of incorpora ...

Flotek Industries, Inc. (NYSE:FTK) Q3 2021 Earnings Conference Call November 9, 2021 10:00 AM ET Corporate Participants Nick Bigney - Senior Vice President, General Counsel and Chief Compliance Officer John Gibson - Chairman, Chief Executive Officer and President Mike Borton - Chief Financial Officer TengBeng Koid – President, Data Analytics Ryan Ezell - President, Chemistry Technologies Conference Call Participants Eric Swergold - Firestorm Capital Daniel Burke - Johnson Rice Jeff Robertson - Water Tower R ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-13270 FLOTEK INDUSTRIES, INC. (Exact name of registrant as specified in its charter) | Delaware | 90-0023731 | | --- | --- | | (State of o ...

Flotek Industries, Inc. (NYSE:FTK) Q2 2021 Earnings Conference Call August 10, 2021 9:30 AM ET Company Participants Nick Bigney - Senior Vice President, General Counsel and Chief Compliance Officer John Gibson - Chairman, Chief Executive Officer & President TengBeng Koid - President, Global Business Ryan Ezell - President, Chemistry Technologies Michael Borton - Chief Financial Officer Conference Call Participants Daniel Burke - Johnson Rice Mike Heim - Noble Financial Eric Swergold - Firestorm Capital John ...

Investor Deck Second Quarter 2021 August 2021 NYSE: FTK Forward Looking Statements Certain statements set forth in this presentation constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-13270 FLOTEK INDUSTRIES, INC. (Exact name of registrant as specified in its charter) | Delaware | 90-0023731 | | --- | --- | | (State of other ...

Financial Data and Key Metrics Changes - The first quarter consolidated revenue was $11.8 million, down 2.8% from $12.1 million in the fourth quarter and significantly below $19.4 million from the same period last year [34] - Adjusted EBITDA for the first quarter was a loss of $6.6 million, an improvement over the previous quarter's loss of $6.8 million and slightly above last year's loss of $6.3 million [39] - Consolidated operating expenses were $13.8 million in the first quarter, a 43.4% decline sequentially and a decrease of 89.6% from last year's level of $22.8 million [35] Business Line Data and Key Metrics Changes - The Chemistry Technology segment saw a 5% decline in revenue sequentially to $10.3 million, primarily due to the termination of the supply agreement with ADM, but excluding terpene sales, the segment improved by 7.1% sequentially [34] - The Data Analytics segment experienced a 16.7% increase in sales sequentially, driven by new product sales in North America, marking the highest performing quarter since the acquisition of JP3 [35] Market Data and Key Metrics Changes - Domestic energy chemistry revenue grew by 56% sequentially despite challenges from Winter Storm Uri, indicating strong demand recovery [34] - International sales were impacted by overall declines in market activity and supply constraints, but progress was made in international business development efforts [21][35] Company Strategy and Development Direction - The company is focusing on green chemistry and data analytics to help clients reduce their environmental impact and improve operational efficiencies [8][45] - A strategic shift in supply chain management aims to align terpene purchases with demand, reducing excess inventory and improving cash flow and margins [14] - The company is actively evaluating actions to improve financial flexibility, including the sale of non-core assets and potential asset-based loans [18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the second quarter, anticipating better performance than the first quarter, driven by improving demand and operational efficiencies [49] - The company is committed to enhancing its ESG initiatives and believes that its green chemistry solutions will play a significant role in the industry's transition to more sustainable practices [8][45] Other Important Information - The company is facing pending litigation related to its terpene supply agreement, but management is confident that it will not materially impact operations [13] - The company has made significant progress in hiring experienced leaders in its Chemistry Technology segment to drive growth [16][30] Q&A Session Summary Question: What does the top-line look like for Q2? - Management anticipates Q2 to be better than Q1, with ongoing improvements in demand and operations [49] Question: Will ceasing the reselling of terpene be a sequential headwind? - Management indicated that while ceasing the sale of terpene may impact top-line revenue, it was necessary to avoid losses from selling at a loss [51] Question: What opportunities exist in professional chemistry? - Management highlighted a diverse portfolio of products and a focus on health and cleanliness, with expectations for continued growth in the professional chemistry market [52][53] Question: How is the transition towards a service model for JP3 progressing? - The company is focused on increasing annual recurring revenue and is making progress in transitioning to a service model [56][58] Question: What is the approach to E&P companies versus oilfield service companies? - Management is engaging with both sectors, emphasizing the importance of chemistry in ESG initiatives and sustainability programs [61][64]

| --- | --- | --- | |---------------------------------|-------|-------| | | | | | | | | | | | | | INVESTOR | | | | PRESENTATION First Quarter 2021 | | | | May 2021 | | | | | | | 9 O Forward Looking Statements Certain statements set forth in this presentation constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and p ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-13270 FLOTEK INDUSTRIES, INC. (Exact name of registrant as specified in its charter) | Delaware | 90-0023731 | | --- | --- | | (State of other ...